KOPRAN - Kopran | Wealthrox

Kopran

KOPRAN · Pharma > Pharmaceuticals & Drugs · Chairman: Susheel G Somani Listing date: Nov. 26, 1994 · Employees: 348 · Mumbai · http://www.kopran.com

Stock Price vs Company Growth

2.3%

2.9%

7.7%

4.3%

11.9%

20.4%

2.8%

10y

12.9%

all

7.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 136 2.3%

120

160

Company Overview

Sales

620 Cr

Growth: -6.6%

Profit after Tax

16.5 Cr

Growth: -6.0%

Small Cap

658 Cr

P/E: 39.8x

Industry P/E: 29.7x

Fundamentals

Sales (Cr)	₹ 620
Growth	-6.6%
EBITDA	7.1%
P/S	1.1x
Dividend	1.0%
P/E	39.8x
Book Value	₹ 109
PEG Ratio	-6.1x
ROE	3.2%
P/B	1.3x

Shareholding Pattern

Institutions

Rikeen Pradip Dalal

1.24 %

Promoters

Oricon Enterprises Limited

13.91 %

Panorama Finvest Pvt.Ltd.

8.79 %

Sarvamangal Mercantile Co.Ltd.

6.71 %

Rajendra Somani

5.37 %

Susheel Somani

2.02 %

Others

Increase Decrease No change

Company Profile Detailed

The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company’s management was acquired by Chemo Pharma Laboratories Ltd and the Company’s products were marketed by them.Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company.

Belongs to (4 Indices)

Investors (63)

modern.t...

bofa.sec...

oricon.e...

Followers (3)

sudheer....

lalit8

kunal9